304 related articles for article (PubMed ID: 16288809)
1. Mechanisms of target organ damage caused by hypertension: therapeutic potential.
Cohuet G; Struijker-Boudier H
Pharmacol Ther; 2006 Jul; 111(1):81-98. PubMed ID: 16288809
[TBL] [Abstract][Full Text] [Related]
2. Hypertension strategies for therapeutic intervention and prevention of end-organ damage.
Houston MC
Prim Care; 1991 Sep; 18(3):713-53. PubMed ID: 1946795
[TBL] [Abstract][Full Text] [Related]
3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the renin-angiotensin system and target organ protection.
Iwanami J; Mogi M; Iwai M; Horiuchi M
Hypertens Res; 2009 Apr; 32(4):229-37. PubMed ID: 19262496
[TBL] [Abstract][Full Text] [Related]
5. Targeting endothelial dysfunction in hypertensive subjects.
Thuillez C; Richard V
J Hum Hypertens; 2005 Jun; 19 Suppl 1():S21-5. PubMed ID: 16075029
[TBL] [Abstract][Full Text] [Related]
6. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
7. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
8. [Rationale for the use of renin-angiotensin inhibitors in the treatment of arterial hypertension and correlated organ damage].
Mammarella A; Paoletti V; De Matteis A; Di Franco M; Cavina G; Paradiso M
Clin Ter; 2002; 153(1):45-9. PubMed ID: 11963634
[TBL] [Abstract][Full Text] [Related]
9. The metabolic syndrome in hypertension: European society of hypertension position statement.
Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G;
J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611
[TBL] [Abstract][Full Text] [Related]
10. [Impact of antihypertensive treatment on target organs].
Fregoso Padilla J
Arch Cardiol Mex; 2002; 72 Suppl 1():S58-63. PubMed ID: 12001872
[TBL] [Abstract][Full Text] [Related]
11. Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes.
Karalliedde J; Viberti G
J Hum Hypertens; 2006 Apr; 20(4):239-53. PubMed ID: 16452996
[TBL] [Abstract][Full Text] [Related]
12. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
Burnier M; Pruijm M; Wuerzner G
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
[TBL] [Abstract][Full Text] [Related]
13. Establishing a new option for target-organ protection: rationale for ARB plus ACE inhibitor combination therapy.
Cohn JN; Goldman JM
Am J Hypertens; 2008 Mar; 21(3):248-56. PubMed ID: 18219303
[TBL] [Abstract][Full Text] [Related]
14. RAS inhibition in hypertension.
Ibrahim MM
J Hum Hypertens; 2006 Feb; 20(2):101-8. PubMed ID: 16397519
[TBL] [Abstract][Full Text] [Related]
15. Which drug should be used to treat patients with uncomplicated essential hypertension?
Rashidi A; Rahman M; Wright JT
Curr Opin Nephrol Hypertens; 2006 May; 15(3):303-8. PubMed ID: 16609299
[TBL] [Abstract][Full Text] [Related]
16. Mediators of target organ damage in hypertension: focus on obesity associated factors and inflammation.
Dawood T; Schlaich MP
Minerva Cardioangiol; 2009 Dec; 57(6):687-704. PubMed ID: 19942842
[TBL] [Abstract][Full Text] [Related]
17. Improving microvascular outcomes in patients with diabetes through management of hypertension.
McGill JB
Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
[TBL] [Abstract][Full Text] [Related]
18. Blocking the renin-angiotensin system: dual- versus mono-therapy.
Ravandi A; Teo KK
Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hypertension based on measurement of blood pressure variability: lessons from animal studies.
Su DF
Curr Opin Cardiol; 2006 Sep; 21(5):486-91. PubMed ID: 16900013
[TBL] [Abstract][Full Text] [Related]
20. [The organ damage in arterial hypertension].
Agabiti-Rosei E; Muiesan ML
Ann Ital Med Int; 1995 Oct; 10 Suppl():99S-107S. PubMed ID: 8562278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
